Oxoquinoline derivatives: Identification and structure-activity relationship (SAR) analysis of new anti-HSV-1 agents

Current Microbiology

Volumn 62, Issue 5, 2011, Pages 1349-1354

  Abreu, Paula A ^a   Da Silva, Viveca A G G ^a   Santos, Fernanda C ^a   Castro, Helena C ^a   Riscado, Cecília S ^a   De Souza, Mariana T ^a   Ribeiro, Camilly P ^a   Barbosa, Juliana E ^a   Dos Santos, Cláudio C C ^b   Rodrigues, Carlos R ^c   Lione, Viviane ^c   Correa, Bianca A M ^c   Cunha, Anna C ^a   Ferreira, Vitor F ^a   De Souza, Maria C B V ^a   Paixão, Izabel C N P ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

6 AZIDO 1,4 DIHYDRO 4 OXOQUINOLINE 3 ETHYL ESTER; ACICLOVIR; AMINO OXOQUINOLINE DERIVATIVE; ANTIVIRUS AGENT; FLUOROXAQ 3B; OXOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HYDROGEN BOND; LIPOPHILICITY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; STATIC ELECTRICITY; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; QUINOLONES; STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS;

HERPES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 79954421189     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-010-9860-6     Document Type: Article

References (21)

1. Aurelian L (2008) Herpes simplex viruses: general features. In: Encyclopedia of virology, 3rd edn. Elsevier Ltd, Amsterdam, pp 383-397
2. J Akhtar D Shukla 2009 Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry FEBS J 276 7228 7236 19878306 10.1111/j.1742-4658.2009.07402.x 1:CAS:528:DC%2BD1MXhsFGqtr3K
3. MN Witt GS Braun S Ihrler, et al. 2009 Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease BMC Pulm Med 18 22 30 10.1186/1471-2466-9-22
4. G Billaud D Thouvenot F Morfin 2009 Drug targets in herpes simplex and Epstein Barr Virus infections Infect Disord Drug Targets 9 117 125 19275700 1:CAS:528:DC%2BD1MXlt1Krtbw%3D
5. ED Clercq 2010 In search of a selective therapy of viral infections Antivir Res 85 19 24 19852983 10.1016/j.antiviral.2009.10.005
6. MH Viera S Amini R Huo, et al. 2010 Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options Int J Dermatol 49 733 749 20618491 1:CAS:528:DC%2BC3cXpslWlsbk%3D
7. C Danve-Szatanek M Aymard D Thouvenot, et al. 2004 Surveillance network for herpes simplex virus resistance to antiviral drugs: a three year follow-up J Clin Microbiol 42 242 249 14715760 10.1128/JCM.42.1.242-249.2004 1:CAS:528:DC%2BD2cXht1Wnt74%3D (Pubitemid 38082727)
8. F Morfin D Thouvenot 2003 Herpes simplex virus resistance to antiviral drugs J Clin Virol 26 29 37 12589832 10.1016/S1386-6532(02)00263-9 1:CAS:528:DC%2BD3sXhtVamtro%3D (Pubitemid 36183346)
9. BA Lucero CRB Gomes ICPP Frugulhetti, et al. 2006 Synthesis and anti-HSV-1 activity of quinolonic acyclovir analogues Bioorg Med Chem Lett 16 1010 1013 16321530 10.1016/j.bmcl.2005.10.111 1:CAS:528:DC%2BD28Xhs1CrtA%3D%3D (Pubitemid 43059869)
10. TM Souza MCB Souza VF Ferreira, et al. 2008 Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(β-d-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone Antivir Res 77 20 27 17931712 10.1016/j.antiviral.2007.08. 011 1:CAS:528:DC%2BD1cXisFylsg%3D%3D
11. GF Duffin JD Kendall 1948 Preparation of 4-hydroxyquinoline derivatives from aromatic amines and ethyl ethoxymethylenemalonate J Chem Soc 70 893 894
12. HR Snyder HE Freier P Kovacic, et al. 1947 Synthesis of 4-hydroxyquinolines. VIII. Some halogen containing 4-aminoquinoline derivatives J Am Chem Soc 69 371 374 10.1021/ja01194a061 1:CAS:528:DyaH2sXhvV2msQ%3D%3D
13. JM Ruxer C Lachoux JB Ousset, et al. 1994 Synthesis of 1, 4-dihydro-4-oxopyrrolo[1, 2b]pyrazine-3-carboxylic acids and 1, 4-dihydro-4-oxoimidazo[1, 5-b]pyridazine-3-carboxyllic acids as antibacterial agents J Heterocycl Chem 31 409 417 10.1002/jhet.5570310228 1:CAS:528: DyaK2cXkvVehtrg%3D (Pubitemid 24183961)
14. K Ramadas N Srinivasan 1992 Iron-ammonium chloride-a convenient and inexpensive reductant Synth Commun 22 3189 3195 10.1080/00397919208021132 1:CAS:528:DyaK3sXhs1ykt7k%3D (Pubitemid 23007903)
15. FC Santos P Abreu HC Castro, et al. 2009 Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives Bioorg Med Chem 17 5476 5481 10.1016/j.bmc.2009.06.037 1:CAS:528:DC%2BD1MXosleitL8%3D
16. AM Bernardino HC Castro IC Frugulhetti, et al. 2008 SAR of a series of anti-HSV-1 acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3, 4-h]-1, 6-naphthyridine series Bioorg Med Chem 16 313 321 17937990 10.1016/j.bmc.2007.09.032 1:CAS:528:DC%2BD1cXlvFSlsA%3D%3D
17. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 6606682 10.1016/0022-1759(83)90303-4 1:STN:280:DyaL2c%2FovFSmtw%3D%3D (Pubitemid 14203433)
18. AM Souza HC Castro MA Brito, et al. 2009 Leishmania amazonensis growth inhibitors: biological and theoretical features of sulfonamide 4-methoxychalcone derivatives Curr Microbiol 59 374 379 19629593 10.1007/s00284-009-9447-2 1:CAS:528:DC%2BD1MXhtVygt73I
19. LC Pinheiro PA Abreu IF Afonso, et al. 2008 Identification of a potential lead structure for designing new antimicrobials to treat infections caused by Staphylococcus epidermidis-resistant strains Curr Microbiol 57 463 468 18810543 10.1007/s00284-008-9234-5 1:CAS:528:DC%2BD1cXht1Chs7fI
20. CA Lipinski F Lombardo BW Dominy, et al. 2001 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 23 3 25 10.1016/S0169-409X(96)00423-1 (Pubitemid 27046991)
21. Wermuth CG (2003) The practice of medicinal chemistry, 2nd edn. University of Louis Pasteur, Academic Press, San Diego, CA